Skip to main content
. 2015 Apr 29;6(16):14344–14359. doi: 10.18632/oncotarget.3852

Table 1. Association of AIB1 amplification with clinicopathologic characteristics in gastric cancers.

Variables AIB1 amplification (n = 133)
Yes No P
No. of patients 47 86
Gender
 Male 67 37 0.91
 Female 19 10
Age, years
 Mean ± SD 62.68 ±13.83 57.38 ±12.33 0.003
 ≤ 50 9 25
 50–60 4 26
 60–70 21 25
 > 70 13 10
Tumor localization
 gastric cardia 16 20 0.41
 gastric body 10 25
 gastric antrum 21 41
Tumor size (cm3)
 ≤ 3 10 33 0.12
 3–5 20 27
 > 5 17 26
Differentiation
 well/moderate 14 43 0.03
 poor/undifferentiation 33 43
Tumor invasion
 T1/T2 8 29 0.04
 T3/T4 39 57
TNM stage
 I 6 25 0.08
 II 8 13
 III 31 44
 IV 2 4
Lymph node metastasis
 Yes 32 49 0.21
 No 15 37
Survival status
 Dead 31 35 0.006
 Alive 16 51